Eton Pharma falls after fourth-quarter loss
18/03/2025 17:17
** Drug developer Eton Pharmaceuticals' ETON.O shares fall 2.2% to $13.39 ** Company posts fourth-quarter net loss of 2 cents per share vs analysts' estimate of break even per share, according to data compiled by LSEG ** Company reports product revenue of $11.65 million vs est $10.53 million ** As of last close, Eton Pharma's shares have more than tripled in the past 12 months (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer